(STZ) Constellation Brands - Overview
Sector: Consumer Defensive | Industry: Beverages - Brewers | Exchange: NYSE (USA) | Market Cap: 28.389m USD | Total Return: -9% in 12m
Industry Rotation: +8.8
Avg Turnover: 316M USD
Peers RS (IBD): 51.9
EPS Trend: 1.2%
Qual. Beats: 0
Rev. Trend: -25.1%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Constellation Brands Inc. (NYSE: STZ) is a diversified alcoholic-beverage company that produces, imports, markets and sells a portfolio of beer, wine and spirits across the United States, Canada, Mexico, New Zealand and Italy. Its flagship beer lineup includes Corona, Modelo and Pacifico, while its wine brands feature Robert Mondavi, Kim Crawford and Ruffino, and its spirits portfolio includes High West, Casa Noble and SVEDKA.
In FY 2023 the company generated $9.6 billion in net sales, up 6% year-over-year, with an adjusted earnings-per-share of $5.55 and free cash flow of $1.9 billion, supporting a dividend yield of roughly 7.8% and a payout ratio near 80%.
Key sector drivers remain strong premiumization trends and the continued expansion of low-calorie and hard-seltzer categories, which have delivered double-digit volume growth for Corona Hard Seltzer. Additionally, resilient consumer spending in the U.S. and favorable exchange-rate dynamics in emerging markets are bolstering margin expansion for the Distillers & Vintners sub-industry.
For a deeper quantitative view, you might want to explore ValueRay’s analyst tools.
- Mexican beer portfolio drives revenue growth
- Wine and spirits segment faces competitive pressures
- Input costs for grains and packaging impact margins
- Regulatory changes in alcohol distribution pose risks
- Consumer discretionary spending influences premium beverage sales
| Net Income: 1.69b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -0.76 > 1.0 |
| NWC/Revenue: 2.37% < 20% (prev -3.12%; Δ 5.49% < -1%) |
| CFO/TA 0.12 > 3% & CFO 2.67b > Net Income 1.69b |
| Net Debt (10.47b) to EBITDA (3.22b): 3.25 < 3 |
| Current Ratio: 1.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (173.7m) vs 12m ago -3.47% < -2% |
| Gross Margin: 51.67% > 18% (prev 0.51%; Δ 5.12k% > 0.5%) |
| Asset Turnover: 41.97% > 50% (prev 47.14%; Δ -5.18% > 0%) |
| Interest Coverage Ratio: 7.80 > 6 (EBITDA TTM 3.22b / Interest Expense TTM 359.1m) |
| A: 0.01 (Total Current Assets 2.91b - Total Current Liabilities 2.69b) / Total Assets 21.90b |
| B: 0.62 (Retained Earnings 13.55b / Total Assets 21.90b) |
| C: 0.13 (EBIT TTM 2.80b / Avg Total Assets 21.78b) |
| D: 0.60 (Book Value of Equity 8.08b / Total Liabilities 13.51b) |
| Altman-Z'' Score: 3.57 = A |
| DSRI: 0.74 (Receivables 658.2m/992.7m, Revenue 9.14b/10.21b) |
| GMI: 0.99 (GM 51.67% / 50.96%) |
| AQI: 1.04 (AQ_t 0.48 / AQ_t-1 0.46) |
| SGI: 0.90 (Revenue 9.14b / 10.21b) |
| TATA: -0.04 (NI 1.69b - CFO 2.67b) / TA 21.90b) |
| Beneish M-Score: -3.35 (Cap -4..+1) = AA |
Over the past week, the price has changed by +7.02%, over one month by +12.02%, over three months by +10.15% and over the past year by -8.97%.
- StrongBuy: 9
- Buy: 7
- Hold: 10
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 172.4 | 3.7% |
P/E Forward = 11.919
P/S = 3.1064
P/B = 3.4004
P/EG = 5.4559
Revenue TTM = 9.14b USD
EBIT TTM = 2.80b USD
EBITDA TTM = 3.22b USD
Long Term Debt = 10.29b USD (from longTermDebt, two quarters ago)
Short Term Debt = 875.6m USD (from shortTermDebt, last quarter)
Debt = 10.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.47b USD (from netDebt column, last quarter)
Enterprise Value = 38.86b USD (28.39b + Debt 10.57b - CCE 102.4m)
Interest Coverage Ratio = 7.80 (Ebit TTM 2.80b / Interest Expense TTM 359.1m)
EV/FCF = 21.66x (Enterprise Value 38.86b / FCF TTM 1.79b)
FCF Yield = 4.62% (FCF TTM 1.79b / Enterprise Value 38.86b)
FCF Margin = 19.63% (FCF TTM 1.79b / Revenue TTM 9.14b)
Net Margin = 18.46% (Net Income TTM 1.69b / Revenue TTM 9.14b)
Gross Margin = 51.67% ((Revenue TTM 9.14b - Cost of Revenue TTM 4.42b) / Revenue TTM)
Gross Margin QoQ = 49.56% (prev 53.23%)
Tobins Q-Ratio = 1.77 (Enterprise Value 38.86b / Total Assets 21.90b)
Interest Expense / Debt = 0.78% (Interest Expense 82.9m / Debt 10.57b)
Taxrate = 36.02% (126.5m / 351.2m)
NOPAT = 1.79b (EBIT 2.80b * (1 - 36.02%))
Current Ratio = 1.08 (Total Current Assets 2.91b / Total Current Liabilities 2.69b)
Debt / Equity = 1.31 (Debt 10.57b / totalStockholderEquity, last quarter 8.08b)
Debt / EBITDA = 3.25 (Net Debt 10.47b / EBITDA 3.22b)
Debt / FCF = 5.83 (Net Debt 10.47b / FCF TTM 1.79b)
Total Stockholder Equity = 7.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.75% (Net Income 1.69b / Total Assets 21.90b)
RoE = 22.08% (Net Income TTM 1.69b / Total Stockholder Equity 7.64b)
RoCE = 15.62% (EBIT 2.80b / Capital Employed (Equity 7.64b + L.T.Debt 10.29b))
RoIC = 9.73% (NOPAT 1.79b / Invested Capital 18.42b)
WACC = 4.99% (E(28.39b)/V(38.96b) * Re(6.66%) + D(10.57b)/V(38.96b) * Rd(0.78%) * (1-Tc(0.36)))
Discount Rate = 6.66% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -2.25%
[DCF] Terminal Value 86.78% ; FCFF base≈1.85b ; Y1≈1.94b ; Y5≈2.25b
[DCF] Fair Price = 323.2 (EV 66.50b - Net Debt 10.47b = Equity 56.03b / Shares 173.4m; r=6.0% [WACC]; 5y FCF grow 4.94% → 3.0% )
EPS Correlation: 1.21 | EPS CAGR: -8.58% | SUE: -0.52 | # QB: 0
Revenue Correlation: -25.11 | Revenue CAGR: -5.39% | SUE: 1.00 | # QB: 2
EPS next Quarter (2026-05-31): EPS=3.35 | Chg7d=-0.003 | Chg30d=+0.004 | Revisions Net=+1 | Analysts=15
EPS current Year (2027-02-28): EPS=12.42 | Chg7d=+0.061 | Chg30d=+0.056 | Revisions Net=-1 | Growth EPS=+5.1% | Growth Revenue=+0.9%
EPS next Year (2028-02-29): EPS=12.96 | Chg7d=-0.020 | Chg30d=-0.021 | Revisions Net=-2 | Growth EPS=+4.4% | Growth Revenue=+1.7%
[Analyst] Revisions Ratio: +0.20 (3 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.0% (Discount Rate 7.9% - Earnings Yield 5.9%)
[Growth] Growth Spread = -6.9% (Analyst -4.9% - Implied 2.0%)